The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review
Authors
Keywords
Interleukin-1, Anakinra, Canakinumab, Gevokizumab, Behçet’s syndrome
Journal
RHEUMATOLOGY INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-25
DOI
10.1007/s00296-019-04259-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and Genetic Aspects of Behçet's Disease in Japan
- (2019) Yohei Kirino et al. INTERNAL MEDICINE
- 2018 update of the EULAR recommendations for the management of Behçet’s syndrome
- (2018) Gulen Hatemi et al. ANNALS OF THE RHEUMATIC DISEASES
- Behçet's disease: New insights into pathophysiology, clinical features and treatment options
- (2018) Antonio Greco et al. AUTOIMMUNITY REVIEWS
- Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies
- (2018) Claudia Fabiani et al. CLINICAL RHEUMATOLOGY
- Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study
- (2018) Jurgen Sota et al. CLINICAL RHEUMATOLOGY
- Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism
- (2018) Antonio Brucato et al. Internal and Emergency Medicine
- Use of Gevokizumab in Patients with Behçet’s Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study
- (2018) Ilknur Tugal-Tutkun et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome
- (2018) Giacomo Emmi et al. Arthritis & Rheumatology
- Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases
- (2018) Giacomo Emmi et al. Current Cardiology Reports
- CSF/serum matrix metallopeptidase-9 ratio discriminates neuro Behçet from multiple sclerosis
- (2018) Alessandra Aldinucci et al. Annals of Clinical and Translational Neurology
- Update on the epidemiology, risk factors and disease outcomes of Behçet's disease
- (2018) Nurullah Akkoç BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study
- (2018) Gerardo Di Scala et al. JOURNAL OF AUTOIMMUNITY
- The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet’s Disease
- (2018) Claudia Fabiani et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review
- (2018) Ana Urruticoechea-Arana et al. RHEUMATOLOGY INTERNATIONAL
- Anakinra Therapy for Non-cancer Inflammatory Diseases
- (2018) Giulio Cavalli et al. Frontiers in Pharmacology
- Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma
- (2017) Ida Orlando et al. INTERNAL MEDICINE JOURNAL
- Ustekinumab for Behçet's disease
- (2017) Adrien Mirouse et al. JOURNAL OF AUTOIMMUNITY
- Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: A multicenter retrospective observational study
- (2017) Giuseppe Lopalco et al. Modern Rheumatology
- Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis
- (2017) Claudia Fabiani et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Dietary and Nondietary Triggers of Oral Ulcer Recurrences in Behçet's Disease
- (2017) Geoffroy Volle et al. ARTHRITIS CARE & RESEARCH
- Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study
- (2017) Serena Colafrancesco et al. Frontiers in Pharmacology
- The Role of Th17 Cells in the Pathogenesis of Behcet’s Disease
- (2017) Yuki Nanke et al. Journal of Clinical Medicine
- Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study
- (2016) Claudia Fabiani et al. CLINICAL RHEUMATOLOGY
- Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study
- (2016) Antonio Vitale et al. CLINICAL RHEUMATOLOGY
- Efficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study
- (2016) Claudia Fabiani et al. CLINICAL RHEUMATOLOGY
- Genetics of Behçetʼs disease
- (2016) Laura T. Morton et al. CURRENT OPINION IN RHEUMATOLOGY
- New therapeutic solutions for Behçet’s syndrome
- (2016) Antonio Vitale et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection
- (2016) Giacomo Emmi et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Rapid desensitization to anakinra-related delayed reaction: Need for a standardized protocol
- (2016) Giacomo Emmi et al. JOURNAL OF DERMATOLOGY
- Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
- (2016) Quan Dong Nguyen et al. LANCET
- Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease
- (2016) Giacomo Emmi et al. MEDICINE
- Adalimumab in Patients with Active Noninfectious Uveitis
- (2016) Glenn J. Jaffe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Gevokizumab in Patients with Behçet’s Disease Uveitis: Results of an Exploratory Phase 2 Study
- (2016) Ilknur Tugal-Tutkun et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Tocilizumab-induced exacerbation of mucosal ulcers in a patient with multi-refractory Behçet׳s disease
- (2016) Giacomo Emmi et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Tocilizumab in severe and refractory Behcet’s disease: Four cases and literature review
- (2016) Alban Deroux et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
- (2016) Antonio Vitale et al. Frontiers in Pharmacology
- Behçet's syndrome patients exhibit specific microbiome signature
- (2015) Clarissa Consolandi et al. AUTOIMMUNITY REVIEWS
- Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet's Disease
- (2015) Matteo Becatti et al. CIRCULATION
- Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study
- (2015) Giacomo Emmi et al. CLINICAL RHEUMATOLOGY
- Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection
- (2015) Antonio Vitale et al. International Journal of Rheumatic Diseases
- Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study
- (2015) Luca Cantarini et al. International Journal of Rheumatic Diseases
- Successful treatment with canakinumab of a paediatric patient with resistant Behçet’s disease
- (2015) Ilaria Pagnini et al. RHEUMATOLOGY
- Tocilizumab for severe refractory neuro-Behçet: Three cases IL-6 blockade in neuro-Behçet
- (2015) Olga Addimanda et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Modern anti-cytokine therapy of autoimmune diseases
- (2014) I. V. Astrakhantseva et al. BIOCHEMISTRY-MOSCOW
- Etanercept in the Treatment of Intestinal Behcet’s Disease
- (2014) Dan Ma et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series
- (2014) Antonio Vitale et al. DERMATOLOGY
- Behçet’s syndrome pathophysiology and potential therapeutic targets
- (2014) Giacomo Emmi et al. Internal and Emergency Medicine
- Resistant Behçet Disease Responsive to Anakinra
- (2013) Costantino Botsios et al. ANNALS OF INTERNAL MEDICINE
- Anakinra treatment in drug-resistant Behcet’s disease: a case series
- (2013) Luca Cantarini et al. CLINICAL RHEUMATOLOGY
- Canakinumab in a patient with juvenile Behçet's syndrome with refractory eye disease: Figure 1
- (2012) Serdal Ugurlu et al. ANNALS OF THE RHEUMATIC DISEASES
- Behçet Syndrome: Is It One Condition?
- (2012) H. Yazici et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study
- (2011) Ahmet Gül et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease
- (2009) Yelda Bilginer et al. CLINICAL RHEUMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now